Navigation Links
Challenges remain in reintroducing American chestnut
Date:9/5/2007

WEST LAFAYETTE, Ind. - Researchers have developed a breed of American chestnut that is resistant to the fungal blight that decimated its population in the early 1900s.

But the return of this "king of trees," so-called for its picturesque form and towering height of more than 100 feet, remains hampered by a slew of obstacles, said a Purdue University researcher.

"We are on the verge of overcoming chestnut blight, but there is a whole new set of obstacles to get past yet," said Douglass Jacobs, an associate professor of forestry and natural resources who is helping develop the blight-resistant chestnut.

To reintroduce the American chestnut, he said, researchers must get past several policy limitations, gather new data, educate the public about the species and address new threats posed by exotic pests. He details these and other challenges in a paper published in July's issue of the journal Biological Conservation.

Once a dominant forest species throughout much of the Eastern United States, ranging from Maine to Mississippi and concentrated in the Appalachian regions, the American chestnut was known for its annual largesse of nuts, rot-resistant wood and sheer size. An introduced Asian fungus nearly eliminated the tree.

A breeding program begun by the American Chestnut Foundation recently produced a blight-resistant hybrid tree that derives its resistance from the Asian chestnut and contains 94 percent of the American chestnut's genetic material, Jacobs said.

Nevertheless, the supply of blight-resistant trees remains low, and the tree isn't likely to be available to the public for about a decade. More resources need to be directed toward breeding programs, he said.

More existing trees also need to be included in breeding programs as soon as possible to produce a genetically diverse population, Jacobs said. Although few adult chestnuts remain throughout the tree's native territory, a significant num
'/>"/>

Contact: Douglas M. Main
dmain@purdue.edu
765-496-2050
Purdue University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Changing ecosystems throw scientists mega-challenges
2. Measurement Challenges In Detecting Cancer Biomarkers
3. Grand Challenges in Global Health initiative funds Yale project
4. Report focuses on challenges to unlocking future promise of vaccines
5. The brain, traffic and nano-circuits -- e-Science takes on major challenges
6. Study challenges myth that sex late in pregnancy hastens birth
7. AIDS study challenges conventional treatment guidelines for HIV patients
8. Chinas environmental challenges
9. New study challenges critical period in childhood vision development
10. Paper challenges 1491 Amazonian population theories
11. The quest for an effective HIV vaccine presents new possibilities, challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... , Jan. 30, 2015  It is gratifying to ... and potential for genomic science as a means to ... prevention and treatment.  I was honored to participate in ... precision medicine program. Since the 1980s ... of genomics—from the first sequenced genome of a free ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced ... Overview" report to their offering. , ... an individual is who she/he is claiming to be, and ... person,s unique physical characteristics, such as fingerprint, hand or palm ...
(Date:1/22/2015)... 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics ... its new website design. "When we launched FindBiometrics ... Peter O,Neill , founder and CEO of FindBiometrics. "Now ... involvement from the key players on a very broad scale.  ...
Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2
... San Diego, Calif. Glioblastoma, the most common and lethal ... because the tumors rapidly become resistant to therapy. As cancer ... growth and drug resistance, they are discovering molecular pathways that ... deadly cancer. Scientists at the Ludwig Institute for Cancer ...
... at the Society of Toxicology,s Annual Meeting and ToxExpo ... that have received growing public attention over the past ... explore how the development of an epidemiological database that ... risk assessment of arsenic in food. While epidemiological studies ...
... Vision and Ophthalmology 2013 Annual Meeting will feature lectures ... the organization,s five-day conference, May 5 9 in ... Series will include Oliver Smithies, DPhil; Roger Tsien, PhD ... University of North Carolina at Chapel Hill, is a ...
Cached Biology News:Novel combination therapy shuts down escape route, killing glioblastoma tumor cells 2Scientists explore topical health issues at meeting in Texas 23 distinguished keynote speakers to present during ARVO 2013 Annual Meeting 2
(Date:3/4/2015)... -- In an article published and posted online today, ... review the clinical aspects of diseases caused by 5 ... article, "Clinical Management of Potential Bioterrorism-Related Conditions," was published ... New England Journal of Medicine . ... Tom Inglesby—review the clinical management of conditions resulting from ...
(Date:3/4/2015)... BROOKLYN, N.Y. , March 4, 2015  Brooklyn ... treat their acute and chronic pain and injuries. ... to announce the grand opening of his NJS Physical ... NY on Thursday, March 5, 2015. Health ... the facility, which is located at 1178 Flatbush Avenue. ...
(Date:3/4/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/nqxxt3/biomarkers ) ... report "Biomarkers - Technologies, Markets and Companies" ... report follows the broad definition of a biomarker ... and evaluated as an indicator of normal biological ... to a therapeutic intervention. Tests based on biomarkers ...
(Date:3/4/2015)... 2015 /CNW/ - Resverlogix Corp. (TSX:RVX) (the "Company") ... collaborative research program with Emerald Logic, a ... Evolution Technology (FACET), Emerald Logic analyzed Resverlogix,s ... from each of 798 patients who participated ... ASSERT, SUSTAIN and ASSURE. The objective of ...
Breaking Biology Technology:Latest Clinical Information On Bioterrorism Threats 2NJS Physical Medicine & Rehabilitation Opening on Flatbush Avenue, Brooklyn, NY 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4
... WALTHAM, Mass., Nov. 10, 2011 Interleukin Genetics, Inc. ... the third quarter ended September 30, 2011. Total ... $765,000, compared to $545,000 for the same period in the ... revenue. Research and development expenses were $325,000 ...
... Inc., a global, full-service testing laboratory with more than ... organs, cells, tissues and implantable biologic products and devices, ... private companies, as judged by the annual ColoradoBiz ... Top 250 Private Companies list is an annual ranking ...
... England Biolabs (NEB), in its continuing commitment to open ... database covering DNA polymerase biochemistry, genetics and structural biology. ... and maintained by NEB), Polbase summarizes the information that ... it easy for researchers to interrogate and use. Polbase ...
Cached Biology Technology:Interleukin Genetics Reports Third Quarter 2011 Financial Results 2Interleukin Genetics Reports Third Quarter 2011 Financial Results 3Interleukin Genetics Reports Third Quarter 2011 Financial Results 4LABS, Inc. Among Colorado's Top Private Companies 2New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers 2
... , Ultima II Series ... Ultima II represents the finest, most enhanced ... and blood bank configurations, each Ultima II ... system with built-in voltage boost and surge ...
...
Verotoxin IIbeta (457)...
Features , Designed to assist users in applying domed caps to tube strips and plates , Minimises the pressure required to seal the caps effectively , Enables multiple tubes to be sealed simultaneousl...
Biology Products: